Cointime

U3 Pharma

company

About

U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug development.

  • 51 - 100

Highlights

Total Funding Amount
€14.35M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€14.35M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2001
Number Of Employee
51 - 100
Operating Status
Active

U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the
ground-breaking discoveries made by its founder - Professor Axel Ullrich.

Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€14.35M
U3 Pharma has raised a total of €14.35M in funding over 2 rounds. Their latest funding was raised on Oct 6, 2003 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 6, 2003 Series Unknown €14.35M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
U3 Pharma is funded by 1 investors. BioM Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
BioM Venture Capital — Series Unknown
Cointime
เนื้อหา
บริษัท